Home » News » Spotlight on Young Researchers: patient-derived mini-tumours for better brain cancer treatment

News

Spotlight on Young Researchers: patient-derived mini-tumours for better brain cancer treatment

30 September 2026 1minute

How can we identify treatments that may help prevent gliomas from returning? In this FNR feature, Anuja Lipsa, postdoctoral researcher in the NORLUX group, explains how patient-derived 3D “mini-tumours” are used to study brain cancer and test how tumour cells respond to different drugs.

Watch the video below and read the full FNR article to learn more about this work and its contribution to research into personalised treatment strategies for high-grade gliomas.

Anuja Lipsa is a biologist and postdoctoral fellow in the NORLUX group at the Luxembourg Institute of Health (LIH).

Scientific Contact

  • Anna
    Golebiewska
    Group Leader, NORLUX Neuro-Oncology Laboratory

    Contact

NORLUX
Neuro-Oncology Laboratory

Share

Related News